Training activity information
Details
Select laboratory molecular assays for patients referred for haematological malignancies investigation, to include:
- CML
- AML
- MPN
- ALL
Type
Entrustable training activity (ETA)
Evidence requirements
Evidence the activity has been undertaken by the trainee repeatedly, consistently, and effectively over time, in a range of situations. This may include occasions where the trainee has not successfully achieved the outcome of the activity themselves. For example, because it was not appropriate to undertake the task in the circumstances or the trainees recognised their own limitations and sought help or advice to ensure the activity reached an appropriate conclusion.
Reflection at multiple timepoints on the trainee learning journey for this activity.
Considerations
- Prioritisation of cases for rapid testing
- Reason for referral and clinical management
- Appropriate test for required turnaround time, sample type and limitations
- Limitations of methodology, including sensitivity
- Selection of the testing pathway according to local and national guidance, as well as the national test directory
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 2 |
Outcome
Select the relevant testing strategy for commonly referred haematological malignancies, including CML, AML, MPN and ALL. |
| # 3 |
Outcome
Evaluate the urgency of testing for particular haematological malignancies to inform management decisions. |